volume 100 issue 3 pages 346-363

An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold

Publication typeJournal Article
Publication date2022-06-01
scimago Q2
wos Q2
SJR0.689
CiteScore5.6
Impact factor3.3
ISSN17470277, 17470285
PubMed ID:  35610776
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
Abstract
Quinoxaline 1,4-di-N-oxides (QdNOs) exhibit multifaceted biological properties, wherein antimicrobial, anticancer, antitrypanosomal, and anti-inflammatory properties are included. Because of their various activities in clinical practice and research, they have a wide spectrum of uses and possibilities. QdNOs have received a significant amount of attention, and research into their medicinal chemistry is still a part of experimental investigation and analytical studies. In this review, QdNOs are classified depending on their actions, which include antibacterial and anti-mycobacterial, anticancer or antitumor, antimalarial, antifungal, and other activities. In a conclusion, it's important to base the development of novel synthetic techniques and the design of new QdNO derivatives on the most up-to-date knowledge gleaned from recent research. With the summarised structure-activity relationship of fascinating QdNOs, this review aims to provide insights into the developments in the chemistry and biological activity of QdNO derivatives.
Found 
Found 

Top-30

Journals

1
2
Letters in Organic Chemistry
2 publications, 22.22%
Compounds
1 publication, 11.11%
European Journal of Medicinal Chemistry
1 publication, 11.11%
ChemistrySelect
1 publication, 11.11%
Pharmaceuticals
1 publication, 11.11%
Archiv der Pharmazie
1 publication, 11.11%
Medicinal Chemistry
1 publication, 11.11%
Mendeleev Communications
1 publication, 11.11%
1
2

Publishers

1
2
3
Bentham Science Publishers Ltd.
3 publications, 33.33%
MDPI
2 publications, 22.22%
Wiley
2 publications, 22.22%
Elsevier
1 publication, 11.11%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 11.11%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
9
Share
Cite this
GOST |
Cite this
GOST Copy
Agrawal N., Bhardwaj A. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold // Chemical Biology and Drug Design. 2022. Vol. 100. No. 3. pp. 346-363.
GOST all authors (up to 50) Copy
Agrawal N., Bhardwaj A. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold // Chemical Biology and Drug Design. 2022. Vol. 100. No. 3. pp. 346-363.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1111/cbdd.14094
UR - https://doi.org/10.1111/cbdd.14094
TI - An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold
T2 - Chemical Biology and Drug Design
AU - Agrawal, Neetu
AU - Bhardwaj, Aditya
PY - 2022
DA - 2022/06/01
PB - Wiley
SP - 346-363
IS - 3
VL - 100
PMID - 35610776
SN - 1747-0277
SN - 1747-0285
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Agrawal,
author = {Neetu Agrawal and Aditya Bhardwaj},
title = {An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold},
journal = {Chemical Biology and Drug Design},
year = {2022},
volume = {100},
publisher = {Wiley},
month = {jun},
url = {https://doi.org/10.1111/cbdd.14094},
number = {3},
pages = {346--363},
doi = {10.1111/cbdd.14094}
}
MLA
Cite this
MLA Copy
Agrawal, Neetu, and Aditya Bhardwaj. “An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold.” Chemical Biology and Drug Design, vol. 100, no. 3, Jun. 2022, pp. 346-363. https://doi.org/10.1111/cbdd.14094.